• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16733 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: ledipasvir-sofosbuvir
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab naïve patients – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Erythrocyte encapsulated asparaginase (GRASPA) for acute lymphoblastic leukaemia — second line
2015     Agency for Healthcare Research and Quality (AHRQ) Management strategies to reduce psychiatric readmissions
2015     Institute of Health Economics (IHE) Optimizing adoption and diffusion of medical devices at the system level
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: sofosbuvir
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for recurrent or metastatic squamous cell carcinoma of the head and neck – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) with paclitaxel and carboplatin for stage IV or recurrent non-small cell lung cancer
2015     Agency for Healthcare Research and Quality (AHRQ) Core functionality for pediatric electronic health records
2015     HAYES, Inc. Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Olaratumab with doxorubicin for advanced soft tissue sarcoma
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for chemotherapy-naïve hormone-relapsed metastatic prostate cancer
2015     NIHR Health Technology Assessment programme Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis
2015     HAYES, Inc. Ultrasound bone growth stimulation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for advanced or metastatic urothelial cancer – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Padeliporfin (Tookad soluble) for localised prostate cancer – first line
2015     NIHR Health Technology Assessment programme An external pilot study to test the feasibility of a randomised controlled trial comparing eye muscle surgery against active monitoring for childhood intermittent exotropia [X(T)]
2015     HAYES, Inc. Decipher prostate cancer classifier
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pegaspargase (Oncaspar) for acute lymphoblastic leukaemia
2015     HAYES, Inc. Autologous fat grafting for breast reconstruction after breast cancer surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib (Stivarga) for hepatocellular carcinoma – second line
2015     NIHR Health Technology Assessment programme The prognostic utility of tests of platelet function for the detection of 'aspirin resistance' in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rindopepimut for EGFRvIII positive glioblastoma multiforme - first line
2015     HAYES, Inc. DUOPA (carbidopa and levodopa) enteral suspension for treatment of Parkinson's disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib for advanced hormone receptor positive, HER2 negative breast cancer – first line
2015     NIHR Health Technology Assessment programme INVESTIGATE-1 (Invasive evaluation before surgical treatment of incontinence gives added therapeutic effect?): A mixed methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women
2015     NIHR Health Technology Assessment programme Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rociletinib for advanced or recurrent non-small cell lung cancer with the EGFR T790M mutation
2015     HAYES, Inc. EpiFix (MiMedx Group) for treatment of non-healing wounds
2015     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The RePneu Coil System and other bronchoscopic lung volume reduction treatments for advanced emphysema
2015     HAYES, Inc. Functional Electrical Stimulation (FES) for treatment of foot drop in multiple sclerosis patients
2015     NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve blocking and gastric artery embolisation for obesity
2015     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Edoxaban tosylate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism [ID662]
2015     HAYES, Inc. Impella 2.5 system (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2015     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Barricaid prosthesis for partial annulus replacement
2015     NIHR Health Technology Assessment programme Enzalutamide for treating metastatic hormone-relapsed prostate cancer not previously treated with chemotherapy
2015     HAYES, Inc. Impella 2.5 system (Abiomed Inc.) for emergent hemodynamic cardiac support in patients with cardiogenic shock
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) for relapsed or refractory acute lymphoblastic leukaemia – third line
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) ZioPatch for diagnosis of cardiac arrhythmias
2015     HAYES, Inc. Impella 5.0 (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2015     Scottish Health Technologies Group (SHTG) Antimicrobial wound dressings (AWDs) for chronic wounds: Health technology assessment report 13
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) ROX Coupler for treatment-resistant hypertension
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2015     NIHR Public Health Research (PHR) programme Analysis of lower limb movement to determine the effect of manipulating the appearance of stairs to improve safety: a linked series of laboratory-based, repeated measures studies
2015     HAYES, Inc. Nucleus hybrid L24 cochlear implant system (Cochlear Limited) for hearing loss
2015     NIHR Horizon Scanning Centre (NIHR HSC) Eprodisate disodium (Kiacta) for AA amyloidosis
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) STAR tumour ablation system
2015     NIHR Health Services and Delivery Research programme Geographical understanding of variation in place of death: the role of care services and end of life care improvement (GUIDE_Care Services)
2015     HAYES, Inc. Pulsed Electromagnetic Field (PEMF) therapy for treatment of postoperative knee pain and edema
2015     NIHR Horizon Scanning Centre (NIHR HSC) STG 320 for allergic rhinitis
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Microwave ablation for liver tumours
2015     NIHR Health Services and Delivery Research programme Impact of a change to remuneration on the technical efficiency of dental practices: evaluation of the pilots of a new NHS Dental Contract in Northern Ireland
2015     HAYES, Inc. Tandem autologous stem cell transplant for Hodgkin lymphoma
2015     NIHR Horizon Scanning Centre (NIHR HSC) Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) ViewRay System for MRI guided radiotherapy
2015     NIHR Health Technology Assessment programme Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pridopidine (Huntexil) for Huntington's disease
2015     Belgian Health Care Knowledge Centre (KCE) Percutaneous vertebroplasty and balloon kyphoplasty
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) InSpace biodegradable subacromial spacer for the treatment of rotator cuff tears
2015     NIHR Health Services and Delivery Research programme What are the determinants of variations in emergency readmission rates and one-year mortality in patients hospitalized with heart failure or chronic obstructive pulmonary disease?
2015     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept solution (Eylea) for visual impairment due to choroidal neovascularisation secondary to pathological myopia
2015     Belgian Health Care Knowledge Centre (KCE) Cervical and lumbar total disc replacements
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Bioresorbable vascular scaffolds
2015     NIHR Health Technology Assessment programme Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation
2015     Agency for Healthcare Research and Quality (AHRQ) Use of cardiac resynchronization therapy in the Medicare population
2015     NIHR Horizon Scanning Centre (NIHR HSC) rhNGF for neurotrophic keratitis – first line
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Transcatheter mitral valve replacement for severe mitral regurgitation
2015     NIHR Health Technology Assessment programme Developing and piloting a peer mentoring intervention to reduce teenage pregnancy in looked-after children and care leavers: an exploratory randomised controlled trial
2015     NIHR Horizon Scanning Centre (NIHR HSC) Abatacept for psoriatic arthritis – second line
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2015     NIHR Health Technology Assessment programme Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bimagrumab for sporadic inclusion body myositis – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L (Prochymal) for steroid refractory acute graft versus host disease – second line
2015     NIHR Public Health Research (PHR) programme Employer schemes to encourage walking to work: feasibility study incorporating an exploratory randomised controlled trial
2015     NIHR Health Technology Assessment programme Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Algisyl-LVR implantable hydrogel (biopolymer) for advanced heart failure
2015     NIHR Health Technology Assessment programme The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2015     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair (the UK Rotator Cuff Surgery (UKUFF) randomised trial)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for choroidal neovascularisation and macular oedema
2015     NIHR Health Technology Assessment programme UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2015     NIHR Horizon Scanning Centre (NIHR HSC) CoSense® End Tidal Carbon Monoxide monitor for neonatal haemolytic disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Idarucizumab for the reversal of anticoagulation due to treatment with dabigatran – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line
2015     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2015     NIHR Health Technology Assessment programme Clinical effectiveness of elemental nutrition for the maintenance of remission in Crohn's disease: a systematic review and meta-analysis
2015     NIHR Health Technology Assessment programme Effectiveness and economic evaluation of self-help educational materials for the prevention of smoking relapse: randomised controlled trial
2015     NIHR Health Technology Assessment programme The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Epratuzumab for systemic lupus erythematosus
2015     NIHR Health Technology Assessment programme Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial
2015     NIHR Health Technology Assessment programme A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol